Intrapartum and 30‐Day Postpartum Complications in Patients With Antenatal COVID‐19 Infection: A Retrospective Cohort Study
Open Access
- 1 January 2024
- journal article
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2024 (1) , 5421129
Abstract
Objective: The study was aimed at comparing intrapartum and postpartum outcomes between pregnant patients with and without antenatal COVID‐19 infection using aggregated, deidentified electronic health record (EHR) data.Design and Setting: This retrospective cohort study included data from over 80 health care organizations within the TriNetX Analytics Research Network.Population: Individuals admitted for delivery from Jan 2020 to May 2023 were studied.Methods: We studied individuals with ICD‐10 codes for delivery, COVID‐19 diagnosis, and primary outcomes. We compared the incidence of adverse intrapartum and 30‐day postpartum outcomes in those with and without antenatal COVID‐19.Main Outcome Measures: The main outcomes compared were obstetric, cardiovascular, neurovascular, and respiratory outcomes within 30 days postpartum.Results: Twenty‐six thousand nine hundred seventy‐four of 369,923 (7%) birthing parents with a delivery encounter had an antenatal COVID‐19 diagnosis. Compared to matched controls, having COVID‐19 was associated with an increased risk of postpartum hemorrhage (RR—1.24 (CI—1.16–1.33)), gestational hypertension (RR—1.27 (CI—1.27–1.34)), preeclampsia (RR—1.25 (CI—1.18–1.32)), eclampsia (RR—1.66 (CI—1.29–2.32)), preterm labor (RR—1.21 (CI—1.21–1.34)), cerebral infarction (RR—1.74 (CI—1.04–2.90)), cardiomyopathy (RR—2.08 (CI—1.30–3.32)), heart failure (RR—1.55 (CI—1.04–2.31)), sepsis (RR—2.21 (CI—1.54–3.19)), DVT (RR—2.32 (CI—1.45–3.71)), and pulmonary embolism (RR—2.68 (CI—1.74–2.90)).Conclusion: Individuals with antenatal COVID‐19 were more likely to have intrapartum and postpartum obstetric, cardiovascular, neurovascular, and respiratory complications. This data will inform risk stratification and screening for prenatal care providers.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UM1TR004528)
- National Institutes of Health
This publication has 24 references indexed in Scilit:
- Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysisAmerican Journal of Obstetrics and Gynecology, 2022
- Comparison of Pregnancy and Birth Outcomes Before vs During the COVID-19 PandemicJAMA Network Open, 2022
- Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networkseClinicalMedicine, 2022
- Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2022
- The etiology of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2022
- SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2022
- Pregnant women with COVID-19: the placental involvement and consequencesJournal of Molecular Histology, 2021
- Clinical characteristics and outcomes of pregnant women with COVID‐19 and comparison with control patients: A systematic review and meta‐analysisReviews in Medical Virology, 2021
- Coronavirus disease 2019 (COVID-19) pandemic and pregnancyAmerican Journal of Obstetrics and Gynecology, 2020
- Acute and chronic respiratory diseases in pregnancy: Associations with placental abruptionAmerican Journal of Obstetrics and Gynecology, 2006